Devi Pharmatech is an API manufacturer based in India. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 3 molecules. Customs aggregates show $609K of exports covering 15 molecules to 5 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Visakhapatnam, India | Not on file |
| Vishakapatnam, India | 3030450565 |
| Molecule | Regulators | Docs |
|---|---|---|
| Bezafibrate | EDQM | 1 |
| Ruxolitinib | US FDA | 1 |
| Triheptanoin | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $302K | 1 |
| 2025 | Not reported | $609K | 5 |
| 2024 | Not reported | $19K | 2 |
| 2023 | Not reported | $3K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Devi Pharmatech comes back tiered against every other supplier able to file there.
Start for free